ZLAB
Zai Lab Limited
NASDAQ · Healthcare · Biotechnology · CN
$26.23
−2.85%Margins
Gross margin
56.5%
EBITDA margin
-37.5%
EBIT margin
-58.7%
Net margin
-41.9%
FCF margin
-36.1%
-31.0%
Return on equity
-17.5%
Return on assets
-30.6%
Return on invested capital
0.41x
Asset turnover
-$133.4M
Cash from operations
$5.50
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026